A Phase II Study of VEGF Trap (NSC 724770) In Patients With MDS.
Phase of Trial: Phase II
Latest Information Update: 07 Jan 2015
At a glance
- Drugs Aflibercept (Primary)
- Indications Myelodysplastic syndromes
- Focus Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 20 Nov 2012 Status changed from completed to recruiting as reported by ClinicalTrials.gov record.
- 14 Jun 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.